Search Results - "Dias Barbosa, C"

Psychometric validation and responder definition of the sleep disturbance numerical rating scale in moderate‐to‐severe atopic dermatitis by Puelles, J., Fofana, F., Rodriguez, D., Silverberg, J.I., Wollenberg, A., Dias Barbosa, C., Vernon, M., Chavda, R., Gabriel, S., Piketty, C.

“…Summary Background Sleep disturbance (SD) is an important part of the burden of atopic dermatitis (AD), but patient‐reported outcomes that are easy to…”
Get full text

Disability related to COPD tool (DIRECT): towards an assessment of COPD-related disability in routine practice by Aguilaniu, B, Gonzalez-Bermejo, J, Regnault, A, Barbosa, C Dias, Arnould, B, Mueser, M, Granet, G, Bonnefoy, M, Similowski, T

“…Chronic Obstructive Pulmonary Disease (COPD) is a worldwide public health concern. It is also a major source of disability that is often overlooked, depriving…”
Get full text

painPREDICT: first interim data from the development of a new patient-reported pain questionnaire to predict treatment response using sensory symptom profiles by Tölle, T. R., Baron, R., de Bock, E., Junor, R., Dias Barbosa, C., Marshall, S. F., Arnould, B., Freynhagen, R.

“…Objective: Sensory symptom patterns may be useful for predicting treatment response, and, thus, improve individual therapy in patients suffering from…”
Get full text

497 FACTORS TO HELP PRIMARY CARE PHYSICIANS DETECTING FIBROMYALGIA IN ROUTINE PRACTICE by Baron, R, Arnould, B, Alegre, C, Choy, E, Cruccu, G, Desmeules, J, Dias-Barbosa, C, Margaux, J, Richards, S, Serra, E, Spaeth, M, Perrot, S

Get full text

Validation of the adherence evaluation of osteoporosis treatment (ADEOS) questionnaire for osteoporotic post-menopausal women by Breuil, V., Cortet, B., Cotté, F.-E., Arnould, B., Dias-Barbosa, C., Gaudin, A.-F., Regnault, A., Roborel de Climens, A., Legrand, E.

“…Summary We developed and validated a specific 12-item questionnaire to evaluate adherence to oral antiresorptive medication by post-menopausal osteoporotic…”
Get full text

Sagit©: A Novel Clinician-Reported Outcome for Managing Acromegaly in Clinical Practice by Giustina, A, Bevan, J, Bronstein, M, Casanueva, F, Chanson, P, Petersenn, S, Truong, Thanh X.M, Massien, C, Dias-Barbosa, C, Guillemin, I, Arnould, B, Melmed, S

Get full text

Preliminary Testing of the Sagit Tool: A Tool to Help Endocrinologists in Their Management of Patients with Acromegaly in Clinical Practice by Giustina, A, Bevan, J, Bronstein, M, Casanueva, F, Chanson, P, Petersenn, S, Truong Thanh, X.M, Massien, C, Dias Barbosa, C, Guillemin, I, Arnould, B, Melmed, S

Get full text

PUK20 Development of a Patient Adherence Specific Scale for Use in the Management of Benign Prostatic Hyperplasia Patients by Amarenco, G, Haab, F, Benjamin, L, Slama, A, Dias barbosa, C, Ruttkay, Y, Bergmann, J.F

Get full text

PMS65 Detecting Potential Fibromyalgia Patients in Primary Care Settings: Validation of the Fibrodetect Screening Tool by Gilet, H, Dias-barbosa, C, Guillemin, I, Baron, R, Perrot, S, Alegre, C, Choy, E, Cruccu, G, Desmeules, J, Margaux, J, Richards, S, Serra, E, Spaeth, M, Arnould, B

Get full text

SAGIT©  : un nouvel outil d’évaluation clinique complet pour la prise en charge de l’acromégalie by Chanson, P, Giustina, A, Bevan, J.S, Bronstein, M.D, Casanueva, F.F, Petersenn, S, Truong Thanh, X.M, Massien, C, Dias Barbosa, C, Guillemin, I, Arnould, B, Melmed, S

“…Introduction L’acromégalie est une maladie rare, due à une production excessive d’hormone de croissance (GH) et d’IGF-1. L’objectif de l’étude SAGIT était…”
Get full text

PMU90 Exploring Symptoms, Impacts, and Patient-Reported Outcome (PRO) Measures in Prurigo Nodularis: A Review of the Literature by Chanis, R., Dias Barbosa, C., Wilson, R., Jabbar-Lopez, Z., Puelles, J., Gabriel, S.

Get full text

A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence by Barbosa, Carla Dias, Balp, Maria-Magdalena, Kulich, Károly, Germain, Nicola, Rofail, Diana

“…To explore the published evidence on the link between treatment satisfaction and patients' compliance, adherence, and/or persistence. Articles published from…”
Get full text

P.690 Impact of second-generation antipsychotic side effects on functioning from a schizophrenia patient perspective: European perspective of a global patient-centered survey by Weiss, C., Meehan, S.R., Lenderking, W., Shalhoub, H., Dias-Barbosa, C., Chen, J., Greene, M., Arango, C.

Get full text

PRS89 - MEASUREMENT OF MAINTENANCE AND RELIEVER USE IN ASTHMA: A SYSTEMATIC REVIEW OF THE LITERATURE by Amin, S., Leighton, P., McHorney, C.A., Dias Barbosa, C., Svangren, P., Cabrera, C.S.

Get full text

PSYCHOMETRIC VALIDATION OF THE FACT-M QUESTIONNAIRE IN PATIENTS WITH MERKEL CELL CARCINOMA by Bharmal, M, Fofana, F, Barbosa, C Dias, Mahnke, L, Schlichting, M

“…OBJECTIVES: Assessment of patient-reported outcomes in oncology clinical trials is required to demonstrate treatment benefit from a patient's perspective. No…”
Get full text

Patient Perspectives on Merkel Cell Carcinoma (MCC) and Its Treatment with A Novel Agent (AVELUMAB): Findings From In-Depth Qualitative Patient Interviews by Kaufman, H, Kraemer, M, Dias Barbosa, C, Lambert, J, Mahnke, L, Bharmal, M

Get full text

PCN206 - Patient Perspectives on Merkel Cell Carcinoma (MCC) and Its Treatment with A Novel Agent (AVELUMAB): Findings From In-Depth Qualitative Patient Interviews by Kaufman, H, Kraemer, M, Dias Barbosa, C, Lambert, J, Mahnke, L, Bharmal, M

Get full text

PRM6 - Using Convergent Mixed Methods To Evaluate Treatment Risks and Benefits In Rare Disease: An Example From A Phase Ii Registration Trial In Metastatic Merkel Cell Carcinoma by Bharmal, M, Guillemin, I, Marrel, A, Lambert, J, Arnould, B, Fatoumata, F, Hennessy, M, Dias-Barbosa, C

Get full text

Using Convergent Mixed Methods To Evaluate Treatment Risks and Benefits In Rare Disease: An Example From A Phase Ii Registration Trial In Metastatic Merkel Cell Carcinoma by Bharmal, M, Guillemin, I, Marrel, A, Lambert, J, Arnould, B, Fatoumata, F, Hennessy, M, Dias-Barbosa, C

“…OBJECTIVES: Demonstrating treatment benefits for rare diseases within clinical trials is challenging. Mixed methods research (MMR) offers to overcome these…”
Get full text

PRM183 - Methotrexate Adherence Questionnaire: a New Tool to Assess Adherence in Patients Treated with Methotrexate by Dias-Barbosa, C, Guillemin, I, Aassi, M, Bernasconi, C, Brethous, M, Reiss, W, Arnould, B, Curtis, JR

Get full text